Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hossam Nada

Showing results (61-70 of 80) with videos related to

Pageof 8
Sort By:
International Journal of Molecular Sciences|March 10, 2022
Identification of Novel and Potent Indole-Based Benzenesulfonamides as Selective Human Carbonic Anhydrase II Inhibitors: Design, Synthesis, In Vitro, and In Silico StudiesAhmed Elkamhawy, Jiyu Woo, Hossam Nada, et al.
Molecules (Basel, Switzerland)|July 14, 2023
Integration of Hybridization Strategies in Pyridine-Urea Scaffolds for Novel Anticancer Agents: Design, Synthesis, and Mechanistic InsightsSreenivasulu Godesi, Hossam Nada, Joohan Lee, et al.
Biomolecules|August 26, 2023
Cantharidin-Based Verbenone Derivatives as a Novel Insecticide against <i>Plutella xylostella</i>: Design, Synthesis, Insecticidal Activity Evaluation, and 3D QSAR StudyKwanshik Lee, Hossam Nada, Minkyoung Kim, et al.
European Journal of Medicinal Chemistry|November 15, 2025
TREM2 activation by first-in-class direct small molecule agonists: DEL screening, optimization, biophysical validation, and functional characterizationHossam Nada, Shaoren Yuan, Farida El Gaamouch, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|March 30, 2022
4-Anilinoquinazoline-based benzenesulfonamides as nanomolar inhibitors of carbonic anhydrase isoforms I, II, IX, and XII: design, synthesis, <i>in-vitro</i>, and <i>in-silico</i> biological studiesHossam Nada, Ahmed Elkamhawy, Magda H Abdellattif, et al.
Biorxiv : the Preprint Server for Biology|December 12, 2025
HTS-Oracle: Experimentally validated AI-enabled prioritization for generalizable small molecule hit discoveryHossam Nada, Laura Calvo-Barreiro, Natalie Fuchs, et al.
Journal of Medicinal Chemistry|March 27, 2023
Perspective for Discovery of Small Molecule IL-6 Inhibitors through Study of Structure-Activity Relationships and Molecular DockingHossam Nada, Aneesh Sivaraman, Qili Lu, et al.
Archiv Der Pharmazie|September 6, 2024
Chalcone-based benzenesulfonamides as potent and selective inhibitors for human carbonic anhydrase II: Design, synthesis, in vitro, and in silico studiesHwa Young Lee, Ahmed Elkamhawy, Ahmed A Al-Karmalawy, et al.
ACS Omega|September 11, 2023
Machine Learning-Based Approach to Developing Potent EGFR Inhibitors for Breast Cancer-Design, Synthesis, and In Vitro EvaluationHossam Nada, Anam Rana Gul, Ahmed Elkamhawy, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
Discovery of a First-in-Class SLIT2 Binder Disrupting the SLIT2/ROBO1 Axis via DNA-Encoded Library (DEL) ScreeningShaoren Yuan, Somaya A Abdel-Rahman, Nelson García Vázquez, et al.
Pageof 8

Showing results (61-70 of 80) with videos related to

Sort By:
Pageof 8
International Journal of Molecular Sciences|March 10, 2022
Identification of Novel and Potent Indole-Based Benzenesulfonamides as Selective Human Carbonic Anhydrase II Inhibitors: Design, Synthesis, In Vitro, and In Silico StudiesAhmed Elkamhawy, Jiyu Woo, Hossam Nada, et al.
Molecules (Basel, Switzerland)|July 14, 2023
Integration of Hybridization Strategies in Pyridine-Urea Scaffolds for Novel Anticancer Agents: Design, Synthesis, and Mechanistic InsightsSreenivasulu Godesi, Hossam Nada, Joohan Lee, et al.
Biomolecules|August 26, 2023
Cantharidin-Based Verbenone Derivatives as a Novel Insecticide against <i>Plutella xylostella</i>: Design, Synthesis, Insecticidal Activity Evaluation, and 3D QSAR StudyKwanshik Lee, Hossam Nada, Minkyoung Kim, et al.
European Journal of Medicinal Chemistry|November 15, 2025
TREM2 activation by first-in-class direct small molecule agonists: DEL screening, optimization, biophysical validation, and functional characterizationHossam Nada, Shaoren Yuan, Farida El Gaamouch, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|March 30, 2022
4-Anilinoquinazoline-based benzenesulfonamides as nanomolar inhibitors of carbonic anhydrase isoforms I, II, IX, and XII: design, synthesis, <i>in-vitro</i>, and <i>in-silico</i> biological studiesHossam Nada, Ahmed Elkamhawy, Magda H Abdellattif, et al.
Biorxiv : the Preprint Server for Biology|December 12, 2025
HTS-Oracle: Experimentally validated AI-enabled prioritization for generalizable small molecule hit discoveryHossam Nada, Laura Calvo-Barreiro, Natalie Fuchs, et al.
Journal of Medicinal Chemistry|March 27, 2023
Perspective for Discovery of Small Molecule IL-6 Inhibitors through Study of Structure-Activity Relationships and Molecular DockingHossam Nada, Aneesh Sivaraman, Qili Lu, et al.
Archiv Der Pharmazie|September 6, 2024
Chalcone-based benzenesulfonamides as potent and selective inhibitors for human carbonic anhydrase II: Design, synthesis, in vitro, and in silico studiesHwa Young Lee, Ahmed Elkamhawy, Ahmed A Al-Karmalawy, et al.
ACS Omega|September 11, 2023
Machine Learning-Based Approach to Developing Potent EGFR Inhibitors for Breast Cancer-Design, Synthesis, and In Vitro EvaluationHossam Nada, Anam Rana Gul, Ahmed Elkamhawy, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
Discovery of a First-in-Class SLIT2 Binder Disrupting the SLIT2/ROBO1 Axis via DNA-Encoded Library (DEL) ScreeningShaoren Yuan, Somaya A Abdel-Rahman, Nelson García Vázquez, et al.
Pageof 8